Designing probiotics with respect to the native microbiome

Future Microbiology

Volumn 7, Issue 5, 2012, Pages 571-575

  Barzegari, Abolfazl ^a   Saei, Amir Ata ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

indigenous; individualized medicine; metagenome; microbiome; prebiotic; probiotic

Indexed keywords

DRUG CARRIER; EXOPOLYSACCHARIDE; PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT;

ATOPIC DERMATITIS; BANANA; BARLEY; BREAST MILK; BRONCHITIS; CARDIOVASCULAR RISK; CLOSTRIDIUM; DRUG EFFICACY; ENTERITIS; FAECALIBACTERIUM PRAUSNITZII; GARLIC; GASTROINTESTINAL TRACT; GENETIC ASSOCIATION; HONEY; HUMAN; HUMAN GENOME; INTESTINE FLORA; LACTOBACILLUS RHAMNOSUS; LIFESTYLE MODIFICATION; METABOLOME; METABOLOMICS; METAGENOMICS; MICROBIOME; NONHUMAN; OAT; ONION; PERSONALIZED MEDICINE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RYE; SOYBEAN; SYMBIONT; WHEAT; WORLD HEALTH ORGANIZATION;

DIET; GASTROINTESTINAL TRACT; HUMANS; METAGENOME; PROBIOTICS;

EID: 84860853504     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.12.37     Document Type: Review

References (52)

1. Berg RD. The indigenous gastrointestinal microflora. Trends Microbiol. 4(11), 430-435 (1996)..... (Pubitemid 26373240)
2. Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI. Human nutrition, the gut microbiome and the immune system. Nature 474(7351), 327-336 (2011)..
3. Sakamoto M, Hayashi H, Benno Y. Terminal restriction fragment length polymorphism analysis for human fecal microbiota and its application for analysis of complex bifidobacterial communities. Microbiol. Immunol. 47(2), 133-142 (2003)..... (Pubitemid 36240892)
4. Dicksved J, Floistrup H, Bergstrom A et al. Molecular fingerprinting of the fecal microbiota of children raised according to different lifestyles. Appl. Environ. Microbiol. 73(7), 2284-2289 (2007). (Pubitemid 46649520)
5. Eckburg PB, Bik EM, Bernstein CN et al. Diversity of the human intestinal microbial flora. Science 308(5728), 1635-1638 (2005). (Pubitemid 40807514)
6. Lay C, Rigottier-Gois L, Holmstrom K et al. Colonic microbiota signatures across five northern European countries. Appl. Environ. Microbiol. 71(7), 4153-4155 (2005). (Pubitemid 40980596)
7. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLoS Biol. 5(7), e177 (2007)...
8. Goodacre R. Metabolomics of a superorganism. J. Nutr. 137(1 Suppl.), 259S-266S (2007)... (Pubitemid 46070106)
9. Mueller S, Saunier K, Hanisch C et al. Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl. Environ. Microbiol. 72(2), 1027-1033 (2006).. (Pubitemid 43271206)
10. Claesson MJ, Cusack S, O'Sullivan O et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc. Natl Acad. Sci. USA 108(Suppl. 1), 4586-4591 (2011)..
11. Erwin GZ. The host genotype affects the bacterial community in the human gastronintestinal tract. Microbial Ecol. Health Disease 13(3), 129-134 (2011)..
12. Turnbaugh PJ, Hamady M, Yatsunenko T et al. A core gut microbiome in obese and lean twins. Nature 457(7228), 480-484 (2009)..
13. Dumas ME, Maibaum EC, Teague C et al. Assessment of analytical reproducibility of 1H NMR spectroscopy based metabonomics for large-scale epidemiological research: the INTERMAP Study. Anal. Chem. 78(7), 2199-2208 (2006)..
14. Vanhoutte T, Huys G, de Brandt E, Swings J. Temporal stability analysis of the microbiota in human feces by denaturing gradient gel electrophoresis using universal and group-specific 16S rRNA gene primers. FEMS Microbiol. Ecol. 48(3), 437-446 (2004).. (Pubitemid 38648930)
15. Zoetendal EG, Akkermans AD, de Vos WM. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl. Environ. Microbiol. 64(10), 3854-3859 (1998). (Pubitemid 28462983)
16. Rajilic-Stojanovic M, Heilig HG, Molenaar D et al. Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environ. Microbiol. 11(7), 1736-1751 (2009)..
17. Proal AD, Albert PJ, Marshall T. Autoimmune disease in the era of the metagenome. Autoimmun. Rev. 8(8), 677-681 (2009)..
18. Holmes E, Loo RL, Stamler J et al. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 453(7193), 396-400 (2008).. (Pubitemid 351693125)
19. Fallani M, Young D, Scott J et al. Intestinal microbiota of 6-week-old infants across europe: geographic influence beyond delivery mode, breast-feeding, and antibiotics. J. Pediatr. Gastroenterol. Nutr. 51(1), 77-84 (2010).
20. de la Cabada BJ, DuPont HL. New developments in traveler's diarrhea. Gastroenterol. Hepatol. 7(2), 88-95 (2011).....
21. Leung AK, Robson WL, Davies HD. Traveler's diarrhea. Adv. Ther. 23(4), 519-527 (2006).....
22. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl Acad. Sci. USA 104(34), 13780-13785 (2007).. (Pubitemid 350003397)
23. Manichanh C, Rigottier-Gois L, , Bonnaud E et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55(2), 205-211 (2006).. (Pubitemid 43117279)
24. Martinez-Medina M, Aldeguer X, Gonzalez- Huix F, Acero D, Garcia-Gil LJ. Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis. Inflamm. Bowel Dis. 12(12), 1136-1145 (2006)... (Pubitemid 44847471)
25. Darfeuille-Michaud A, Boudeau J, Bulois P et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127(2), 412-421 (2004)... (Pubitemid 39091889)
26. Kotlowski R, Bernstein CN, Sepehri S, Krause DO. High prevalence of Escherichia coli belonging to the β2+D phylogenetic group in inflammatory bowel disease. Gut 56(5), 669-675 (2007). (Pubitemid 46662933)
27. Turnbaugh PJ, Ley RE, Hamady M et al. The human microbiome project. Nature 449, 804-810 (2007). (Pubitemid 47598620)
28. Pham M, Lemberg DA, Day AS. Probiotics: sorting the evidence from the myths. Med. J. Aust. 188(5), 304-308 (2008)...
29. Morrow LE, Kollef MH. Probiotics in the intensive care unit: why controversies and confusion abound. Crit. Care 12(3), 160 (2008)...
30. Caramia G. Gastroenteric pathology and probiotics: from myth to scientific evidence. Current aspects. Minerva Gastroenterol. Dietol. 55(3), 237-272 (2009).
31. Gruber C, Wendt M, Sulser C et al. Randomized, placebo-controlled trial of Lactobacillus rhamnosus GG as treatment of atopic dermatitis in infancy. Allergy 62(11), 1270-1276 (2007)... (Pubitemid 47537520)
32. Folster-Holst R, Muller F, Schnopp N et al. Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis. Br. J. Dermatol. 155(6), 1256-1261 (2006)... (Pubitemid 44730004)
33. Rose MA, Stieglitz F, Koksal A, Schubert R, Schulze J, Zielen S. Efficacy of probiotic Lactobacillus GG on allergic sensitization and asthma in infants at risk. Clin. Exp. Allergy 40(9), 1398-1405 (2010)...
34. Brouwer ML, Wolt-Plompen SA, Dubois AE et al. No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. Clin. Exp. Allergy 36(7), 899-906 (2006)... (Pubitemid 43972956)
35. Rosenfeldt V, Benfeldt E, Nielsen SD et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J. Allergy Clin. Immunol. 111(2), 389-395 (2003)... (Pubitemid 36228562)
36. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin. Exp. Allergy 30(11), 1604-1610 (2000).
37. Viljanen M, Savilahti E, Haahtela T et al. Probiotics in the treatment of atopic eczema/ dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 60(4), 494-500 (2005)... (Pubitemid 40332976)
38. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J. Allergy Clin. Immunol. 99(2), 179-185 (1997)... (Pubitemid 27091565)
39. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357(9262), 1076-1079 (2001)... (Pubitemid 32322538)
40. Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361(9372), 1869-1871 (2003)..... (Pubitemid 36645184)
41. Kalliomaki M, Salminen S, Poussa T, Isolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 119(4), 1019-1021 (2007). (Pubitemid 46527807)
42. Kopp MV, Hennemuth I, Heinzmann A, Urbanek R. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 121(4), e850-e856 (2008)...
43. Michail SK, Stolfi A, Johnson T, Onady GM. Efficacy of probiotics in the treatment of pediatric atopic dermatitis: a meta-analysis of randomized controlled trials. Ann. Allergy Asthma Immunol. 101(5), 508-516 (2008)..
44. van der Aa LB, Heymans HS, van Aalderen WM, Sprikkelman AB. Probiotics and prebiotics in atopic dermatitis: review of the theoretical background and clinical evidence. Pediatr. Allergy Immunol. 21(2 Pt 2), e355-e367 (2010).....
45. Salminen MK, Tynkkynen S, Rautelin H et al. Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin. Infect. Dis. 35(10), 1155-1160 (2002)... (Pubitemid 35305862)
46. Besselink MG, van Santvoort HC, Buskens E et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371(9613), 651-659 (2008).....
47. Grzeskowiak L, Isolauri E, Salminen S, Gueimonde M. Manufacturing process influences properties of probiotic bacteria. Br. J. Nutr. 105(6), 887-894 (2011)...
48. Salazar N, Gueimonde M, Hernandez- Barranco AM, Ruas-Madiedo P, de los Reyes-Gavilan CG. Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria. Appl. Environ. Microbiol. 74(15), 4737-4745 (2008)...
49. Slavin J. Gut feelings. Prebiotic food products play a growing role in good intestinal health. Food Processing USA 58(5), 67 (1997)....
50. Walker WA, Duffy LC. Diet and bacterial colonization: role of probiotics and prebiotics. J. Nutr. Biochem. 9(12), 668-675 (1998)... (Pubitemid 28564516)
51. Steer T, Carpenter H, Tuohy K, Gibson GR. Perspectives on the role of the human gut microbiota and its modulation by pro- and prebiotics. Nutr. Res. Rev. 13(2), 229-254 (2000)...... (Pubitemid 32125097)
52. Coppa GV, Bruni S, Morelli L, Soldi S, Gabrielli O. the first prebiotics in humans: human milk oligosaccharides. J. Clin. Gastroenterol. 38(6 Suppl.), S80-S83 (2004).